Fundz

Curevo reported raising $42.4 Million in an initial SEC Form D filing, from an offering of $84.8 Million

RECENTLY ACQUIREDMar 18, 2025$42.4M of $84.8M raised

Amount Raised

$42.4 Million

$42.4 Million sold, per SEC Form D (first sale Mar 6, 2025)

Round Type

Venture

SeattleBiotechnologyHealthcareMobileSportsPlatforms

Quick answer

Curevo raised $42.4 Million in a funding round, dated March 6, 2025. Curevo is based in Seattle, Washington, United States.

How much did Curevo raise?
Curevo raised $42.4 Million in a funding round on March 6, 2025.
What does Curevo do?
Curevo is a clinical-stage biotechnology company dedicated to developing vaccines with improved tolerability and accessibility.
Where is Curevo based and how big is it?
Curevo is based in Seattle, Washington, United States. Fundz records about 44 employees.
Who are the decision-makers at Curevo?
Fundz holds 2 contacts at Curevo, including the CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Mobile around the same time

Companies in the same sectors as Curevo that raised within 45 days of this round, from Fundz verified event records.

  • Alessa Therapeutics raised $25M on April 18, 2025.
  • Singletto raised $10M on April 15, 2025.
  • Shape Memory Medical raised $4.4M (Series C) on April 15, 2025.
  • Flyte raised $137K (Seed) on April 15, 2025.
  • Akadeum Life Sciences raised $5.6M on April 11, 2025.
  • Talphera, Inc. raised $4.9M (Seed) on April 2, 2025.

Who to call at Curevo, and when

A new round usually means Curevo is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Curevo raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Curevo, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Curevo. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Curevo

Location

Seattle, Washington, United States

About

Curevo is a clinical-stage biotechnology company dedicated to developing vaccines with improved tolerability and accessibility. Its lead product is amezosvatein, a non-mRNA adjuvanted sub-unit vaccine to prevent shingles, a serious medical condition involving a painful, blistering skin rash where 10-18% of people also develop serious, long-lasting nerve pain.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Curevo raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsGeorge S., CEO hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Curevo's next move

See what Strategic adds

Curevo raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.